Birte E. H.
- Country
- Germany
- Department
- 6723: Private Practice
Research Overview
- A Randomized, Double-Blind, Parallel-Group Study Comparing Remibrutinib and Teriflunomide in Relapsing Multiple Sclerosis Patients, with Open-Label Remibrutinib Extension
- Evaluation of Ofatumumab Concentration in Breast Milk of Lactating Women with Relapsing Multiple Sclerosis Receiving Ofatumumab Therapy
- Phase 3 Extension Study on Long-term Safety and Tolerability of Tolebrutinib in Relapsing and Progressive Multiple Sclerosis
Data & Insights
Has run more than one trial at 111 of 286 partner sites.
Specializations
Multiple Sclerosis Research Focus
This investigator specializes in the study of relapsing forms of multiple sclerosis (RMS), with particular emphasis on advanced therapeutic approaches and treatment evaluation.
- Relapsing-remitting Multiple Sclerosis
- Progressive Multiple Sclerosis
- Clinically Isolated Syndrome
The investigator's work encompasses comprehensive assessment of innovative treatments for neurological conditions.
Treatment Monitoring
Expertise in evaluating long-term safety and tolerability of various therapeutic agents, including targeted immunotherapies and novel compounds for multiple sclerosis treatment.
- Therapeutic Drug Monitoring
- Safety Assessment
- Treatment Effectiveness
The research includes extensive monitoring of treatment responses and patient outcomes.
Specialized Clinical Areas
Focus on maternal health considerations in multiple sclerosis treatment, including specialized research in pregnancy and lactation-related therapeutic challenges.
- Pregnancy-related MS Management
- Post-partum Treatment
- Infant Safety Monitoring
The investigator conducts targeted research on treatment safety during reproductive periods.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.